For two decades, the demand for emergency department services in Australia has outpaced population growth and wait times have increased. In 2022-2023 more than 8.8 million emergency department presentations occurred nationwide.
While demand is a contributing factor, EDs are currently being impacted by various factors across the entire health system.
The Emergency Medicine Foundation (EMF) is a non-profit organisation funding innovative Australian research that improves the way people are cared for in a medical emergency. The aim of the research is to deliver better and more effective health services to save lives and money.
Professor Hugh Grantham, Emergency Medicine Foundation (EMF) Chair on the urgent challenges in emergency departments states, “The issue of system-wide delays from triage to admission to treatment and discharge is one of the Australian healthcare system’s most challenging problems and it severely impacts vulnerable patient groups, including aged care and mental health patients.”
In February 2024, the Emergency Medicine Foundation (EMF) launched a $1.3 million fund for new research grants dedicated to addressing the pressing issues in emergency care to improve patient outcomes in Australia.
These projects will include innovative ways to improve pain management in children, treating diabetic patients, and optimising treatment for patients who call an ambulance for nausea or vomiting.
Australian Health Journal spoke with Dr Kim Hansen, Emergency Medicine Foundation Board Director, author & presenter of a broad range of topics including ED crowding, incident reporting, cognitive bias and gender equity.
Since launching in 2007, EMF has fostered significant growth in research and innovation in emergency, prehospital and retrieval medicine across Queensland. These EMF-funded research projects have proved both effective and wide-reaching, with a recent mental health study projected to save the Australian health system $30 million.
You Might also like
-
Supporting women in arthroplasty, surgery & orthopaedic oncology
Associate Professor Claudia Di Bella is an academic orthopaedic surgeon based in Melbourne, specialising in orthopaedic oncology and complex joint reconstruction. Originally trained at the world-renowned Rizzoli Orthopaedic Institute (Istituto Ortopedico Rizzoli) in Bologna, Italy, she moved to Australia in 2010 and was awarded Fellowship of the Royal Australasian College of Surgeons in 2013.
-
Growing impact of blood cancer on women
According to the Leukaemia Foundation, blood cancer is one of the most urgent and under-recognised women’s health issues in Australia, with three times more Australian women diagnosed with blood cancer than ovarian and cervical cancer combined (Source: AIHW, Cancer Data in Australia, 2024).
Blood cancer has also emerged as the second most common cancer diagnosed in Australian women overall – behind only breast cancer – and the leading cancer amongst girls and women under the age of 30 (Source: AIHW, Cancer Data in Australia, 2024).
-
Greater flexibility in medicine safety programs delivered by pharmacists
Addressing delegates at PSA26, the Pharmaceutical Society of Australia’s (PSA) yearly conference, the Minister for Health and Ageing, the Hon. Mark Butler MP, announced negotiations are progressing on the First Pharmacy Programs Agreement (1PPA), and that from 1 November, follow-up services for Home Medicines Reviews (HMRs) and Residential Medication Management Reviews (RMMRs) programs will be able to be delivered via telehealth.